Related Articles
Large cell neuroendocrine carcinoma of the lung that responded to nivolumab: A case report
PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series
Application of PD‑L1 blockade in refractory histiocytic sarcoma: A case report
Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer